Plasma Therapy Market Size Projected to Reach $1194 million by 2034 | 7.5%

According to Straits Research, the global plasma therapy market size was valued at $620 million in 2025 and is projected to grow from $669 million in 2026 to $1,194 million by 2034 at a CAGR of 7.5% during the forecast period 2026-2034.

The plasma therapy market is primarily driven by its integral use in the healthcare industry for treating orthopedic injuries, cosmetic surgeries, and immunodeficiency disorders. Orthopedic injuries such as tendon injuries, rotator cuff, tennis elbow, and hamstring are quickly and effectively healed using plasma therapy.

Several medical conditions, such as erectile dysfunction and facelift surgeries, are treated using platelet-rich plasma therapy. Platelet-rich plasma is derived from blood plasma, consisting enriched platelets, which assists in quick healing of bone and other soft tissues. However, high cost of medical devices used in plasma therapy hampers market growth. Governments across the globe are actively working to develop plasma-derived medicines and organizing blood donation to ensure an adequate supply of blood plasma, further driving the market growth.  For instance, the government of India announced the national policy to access plasma-derived medicinal products for clinical and therapeutic use. 

Key Highlights

• The pure platelet rich plasma segment holds the largest market share owing to the effective results of pure PRP therapy and widespread applications in cosmetics, general, cardiovascular surgeries, and wound healing surgeries
• The autologous segment is expected to account for the largest market share during the forecast period owing to its cost-effectiveness and low threat of disease transmission
• North America leads the plasma therapy market as the region possesses well-established healthcare infrastructure, favorable regulatory framework, and government support

Market Segments

1. By Type
   1. Pure Platelet-Rich Plasma
   2. Leukocyte-Rich PRP
   3. Pure Platelet-Rich Fibrin
   4. Leukocyte-Rich Fibrin
   5. Plasma Proteins
2. By Source
   1. Autologous
   2. Allogenic
3. By Application
   1. Orthopedic
   2. Chronic Infectious Diseases
   3. Dermatology
   4. Dental
   5. Cardiac Muscle Injury
   6. Nerve Injury
4. By End User
   1. Hospitals & Clinics
   2. Research Institutions